Global Human Milk Oligosaccharides HMO Market Research Report 2023(Status and Outlook)
Report Overview
Human milk oligosaccharides (HMOs) are a family of structurally diverse unconjugated glycan’s that are found in and unique to human breast milk, despite not actually being digestible by human infants. HMOs function as a prebiotic helping to establish commensal bacteria. HMOs also function as anti-adhesives that help prevent the attachment of microbial pathogens to mucosal surfaces. Human milk oligosaccharides are manufactured through numerous processes which involve the use of several chemicals, enzymes or microbes. The technology used for manufacturing of human milk oligosaccharides is very complex and expensive, thus restricting their large-scale production. Major players have been increasing investing increasingly on R&D for low-cost production and the introduction of effective technologies for product synthesis.
Global Human Milk Oligosaccharides (HMO) key players include Abbott, Inbiose, Elicityl SA, Jennewein Biotechnologie, ZuChem, etc. North America is the largest consumption market, with a share about 65%, followed by Europe, with a share about 30 percent. In terms of product, 2'-FL & 3-FL is the largest segment, with a share about 70%. And in terms of application, the largest application is Infant Formula, followed by Functional Food & Beverages, and Food/Medical Supplements.
The Global Human Milk Oligosaccharides HMO Market Size was estimated at USD 385.00 million in 2022 and is projected to reach USD 2494.96 million by 2029, exhibiting a CAGR of 30.60% during the forecast period.
Bosson Research’s latest report provides a deep insight into the global Human Milk Oligosaccharides HMO market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Human Milk Oligosaccharides HMO Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Human Milk Oligosaccharides HMO market in any manner.
Global Human Milk Oligosaccharides HMO Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Abbott
Inbiose
Elicityl SA
Jennewein Biotechnologie
ZuChem
Dextra Laboratories
Glycom
Market Segmentation (by Type)
2'-FL & 3-FL
Sialyllactose
LNT & LNnT
Market Segmentation (by Application)
Shopping Malls
Baby Store
Online Channel
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Human Milk Oligosaccharides HMO Market
Overview of the regional outlook of the Human Milk Oligosaccharides HMO Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors